文献速递神经肿瘤

间变性脑膜瘤:2004年至2012年美国国家癌症数据库分析

Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.
PubMed 文献 · J Neurosurg · 2017-07-21

该研究利用美国国家癌症数据库识别2004年至2012年间诊断为间变性脑膜瘤的755例成人患者,5年总生存率为41.4%。52%接受放疗,7%接受化疗,58%接受全切除。多因素分析显示全切除和放疗与死亡风险降低相关,而化疗未显示生存获益。

要点

  • 间变性脑膜瘤5年总生存率为41.4%。
  • 全切除(HR 1.57,次全切除对比全切除)和放疗(HR 0.79)与生存改善相关。
  • 化疗未显示生存获益(HR 1.33,p=0.18)。

核心结论

  • 间变性脑膜瘤预后差,全切除和放疗与生存改善相关,但放疗使用率低,除非有医疗禁忌,应给予放疗。

研究设计与样本

  • 使用美国国家癌症数据库识别2004年至2012年诊断为间变性脑膜瘤的患者,共755例成人。

主要发现

  • 5年总生存率为41.4%。
  • 52%的患者接受放疗,7%接受化疗,58%接受全切除。
  • 多因素分析中,年龄较大(HR 1.04,p<0.01)、高合并症评分(HR 1.33,p=0.02)和次全切除(HR 1.57,p=0.02)与死亡风险增加相关,接受放疗与死亡风险降低相关(HR 0.79,p=0.04)。
  • 化疗未显示对生存的影响(HR 1.33,p=0.18)。
  • 年龄较大的患者接受放疗的可能性较低(OR 0.98,p<0.01)。

临床怎么用

  • 作者建议,除非有医疗禁忌,间变性脑膜瘤患者应接受放疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Anaplastic meningiomas represent 1%-2% of meningioma diagnoses and portend a poor prognosis. Limited information is available on practice patterns and optimal management. The purpose of this study was to define treatment patterns and outcomes by treatment modality using a large national cancer registry. METHODS The National Cancer Database was used to identify patients diagnosed with anaplastic meningioma from 2004 to 2012. Log-rank statistics were used to compare survival outcomes by extent of resection, use of adjuvant radiotherapy (RT), and use of adjuvant chemotherapy. Least-squares linear regression was used to evaluate the utilization of RT over time. Logistic regression modeling was used to identify predictors of receipt of RT. Cox proportional hazards modeling was used to evaluate the effect of RT, gross-total resection (GTR), and chemotherapy on survival. RESULTS A total of 755 adults with anaplastic meningioma were identified. The 5-year overall survival rate was 41.4%. Fifty-two percent of patients received RT, 7% received chemotherapy, and 58% underwent GTR. Older patients were less likely to receive RT (OR 0.98, p < 0.01). Older age (HR 1.04, p < 0.01), high comorbidity score (HR 1.33, p = 0.02), and subtotal resection (HR 1.57, p = 0.02) were associated with increased risk of death on multivariate modeling, while RT receipt was associated with decreased risk of death (HR 0.79, p = 0.04). Chemotherapy did not have a demonstrable effect on survival (HR 1.33, p = 0.18). CONCLUSIONS Anaplastic meningioma portends a poor prognosis. Gross-total resection and RT are associated with improved survival, but utilization of RT is low. Unless medically contraindicated, patients with anaplastic meningioma should be offered RT.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Orton A, Frandsen J, Jensen R, et al. Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012. J Neurosurg. 2017. PMID: 28731397. doi:10.3171/2017.2.JNS162282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。